Acute On Chronic Liver Failure clinical trials

Explore recruiting acute on chronic liver failure clinical trials.

Recruiting acute on chronic liver failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute On Chronic Liver Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital Mortality

France, Germany, Belgium, Spain, Italy, Austria +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, open-label, randomized, controlled, multi-center, proof of concept study, to assess the efficacy, safety, and tolerability of VS-01 on top of standard of care, compared to standard of care alone, in adult patients with acute-on-chronic liver failure (ACLF)

Germany, Belgium, Spain, France, Hungary, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, placebo-controlled, double blind, multi-centre Phase IIb stuDy to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) – DHELIVER

Denmark, Poland, Bulgaria, Netherlands, Slovakia, Latvia +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF).

Germany, Spain, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A Single-blind, Phase 2, Multi-center, Randomized Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the Relaxin Agonist R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients with Hepatorenal Syndrome – Acute Kidney Injury

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Norfloxacin for amelioration of portal hypertension in decompensated cirrhosis - a randomized, placebo-controlled, double-blinded clinical trial

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute On Chronic Liver Failure trials by city

Acute On Chronic Liver Failure in Toronto Acute On Chronic Liver Failure in Vancouver Acute On Chronic Liver Failure in Montreal Acute On Chronic Liver Failure in Calgary Acute On Chronic Liver Failure in Edmonton Acute On Chronic Liver Failure in Ottawa Acute On Chronic Liver Failure in Winnipeg Acute On Chronic Liver Failure in Quebec City Acute On Chronic Liver Failure in Hamilton Acute On Chronic Liver Failure in Kitchener Acute On Chronic Liver Failure in London Acute On Chronic Liver Failure in Halifax Acute On Chronic Liver Failure in New York Acute On Chronic Liver Failure in Los Angeles Acute On Chronic Liver Failure in Chicago Acute On Chronic Liver Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease